INTEGRA Biosciences

INTEGRA Biosciences

Is this your company? Claim your profile to update info and connect with investors.
Claim profile

Private Company

Funding information not available

Overview

INTEGRA Biosciences is a privately held, revenue-generating company specializing in laboratory tools for liquid handling and automation. Operating in the diagnostics and drug delivery sectors, it provides essential instrumentation that accelerates research workflows and reduces manual error. With a long-standing presence since 1996, the company has established a global footprint, serving the core needs of life sciences laboratories. Its business model is based on the sale of instruments, consumables, and associated services.

DiagnosticsDrug Delivery

Technology Platform

Precision liquid handling and laboratory automation platform encompassing electronic pipettes, reagent dispensers, and modular robotic workstations, focused on improving workflow efficiency and reproducibility in life sciences research and diagnostics.

Funding History

1
Series AUndisclosed

Opportunities

The growing demand for laboratory automation from mid-sized labs and the expansion of genomic and diagnostic testing present significant growth opportunities.
INTEGRA's focus on flexible, cost-effective automation solutions positions it well to capture market share from labs transitioning from manual processes.

Risk Factors

Intense competition from larger, well-capitalized players like Thermo Fisher and Danaher poses a constant threat.
The company is also exposed to cyclical swings in research funding and capital equipment budgets from its academic and biopharma customers.

Competitive Landscape

INTEGRA operates in a highly competitive market dominated by large conglomerates (Thermo Fisher, Danaher, Agilent) and strong pure-play competitors (Mettler Toledo, Tecan, Hamilton Company). It differentiates through ergonomic design, flexible automation at a lower entry cost, and a strong focus on user experience and contamination control.